123 related articles for article (PubMed ID: 23477365)
1. The development of highly potent inhibitors for porcupine.
Wang X; Moon J; Dodge ME; Pan X; Zhang L; Hanson JM; Tuladhar R; Ma Z; Shi H; Williams NS; Amatruda JF; Carroll TJ; Lum L; Chen C
J Med Chem; 2013 Mar; 56(6):2700-4. PubMed ID: 23477365
[TBL] [Abstract][Full Text] [Related]
2. Modulators for palmitoylation of proteins and small molecules.
Fan Z; Hao Y; Huo Y; Cao F; Li L; Xu J; Song Y; Yang K
Eur J Med Chem; 2024 May; 271():116408. PubMed ID: 38621327
[TBL] [Abstract][Full Text] [Related]
3. Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer.
Liu Z; Wang P; Wold EA; Song Q; Zhao C; Wang C; Zhou J
J Med Chem; 2021 Apr; 64(8):4257-4288. PubMed ID: 33822624
[TBL] [Abstract][Full Text] [Related]
4. Determination of the membrane topology of PORCN, an O-acyl transferase that modifies Wnt signalling proteins.
Galli LM; Anderson MO; Gabriel Fraley J; Sanchez L; Bueno R; Hernandez DN; Maddox EU; Lingappa VR; Burrus LW
Open Biol; 2021 Jun; 11(6):200400. PubMed ID: 34186010
[TBL] [Abstract][Full Text] [Related]
5. Identification of multiple structurally distinct, nonpeptidic small molecule inhibitors of protein arginine deiminase 3 using a substrate-based fragment method.
Jamali H; Khan HA; Stringer JR; Chowdhury S; Ellman JA
J Am Chem Soc; 2015 Mar; 137(10):3616-21. PubMed ID: 25742366
[TBL] [Abstract][Full Text] [Related]
6. Cell biology. The unusual case of Porcupine.
Lum L; Clevers H
Science; 2012 Aug; 337(6097):922-3. PubMed ID: 22923569
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of potent novel inhibitors of human sulfide:quinone oxidoreductase.
Baugh SDP; Jackson MR; Rashad AA; Reitz AB; Lam PYS; Jorns MS
Bioorg Med Chem Lett; 2021 Dec; 54():128443. PubMed ID: 34763081
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule inhibitors of carboxylesterase Notum.
Zhao Y; Jolly S; Benvegnu S; Jones EY; Fish PV
Future Med Chem; 2021 Jun; 13(11):1001-1015. PubMed ID: 33882714
[TBL] [Abstract][Full Text] [Related]
9. Covalent inhibition of the lymphoid tyrosine phosphatase.
Ahmed VF; Bottini N; Barrios AM
ChemMedChem; 2014 Feb; 9(2):296-9. PubMed ID: 24403103
[TBL] [Abstract][Full Text] [Related]
10. Porcn as a novel therapeutic target in cancer therapy: A review.
Raeisi M; Saberivand M; Velaei K; Aghaei N; Rahimi-Farsi N; Kharrati-Shishavan H; Hassanzadeh D; Mehdizadeh A
Cell Biol Int; 2022 Dec; 46(12):1979-1991. PubMed ID: 35971741
[TBL] [Abstract][Full Text] [Related]
11. Structural model of human PORCN illuminates disease-associated variants and drug-binding sites.
Yu J; Liao PJ; Xu W; Jones JR; Everman DB; Flanagan-Steet H; Keller TH; Virshup DM
J Cell Sci; 2021 Dec; 134(24):. PubMed ID: 34817055
[TBL] [Abstract][Full Text] [Related]
12. Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling.
Bayle ED; Svensson F; Atkinson BN; Steadman D; Willis NJ; Woodward HL; Whiting P; Vincent JP; Fish PV
J Med Chem; 2021 Apr; 64(8):4289-4311. PubMed ID: 33783220
[TBL] [Abstract][Full Text] [Related]
13. Enriching the Arsenal of Pharmacological Tools against MICAL2.
Barravecchia I; Barresi E; Russo C; Scebba F; De Cesari C; Mignucci V; De Luca D; Salerno S; La Pietra V; Giustiniano M; Pelliccia S; Brancaccio D; Donati G; Da Settimo F; Taliani S; Angeloni D; Marinelli L
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946600
[TBL] [Abstract][Full Text] [Related]
14. Disruption of Wnt/β-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells.
Kulak O; Chen H; Holohan B; Wu X; He H; Borek D; Otwinowski Z; Yamaguchi K; Garofalo LA; Ma Z; Wright W; Chen C; Shay JW; Zhang X; Lum L
Mol Cell Biol; 2015 Jul; 35(14):2425-35. PubMed ID: 25939383
[TBL] [Abstract][Full Text] [Related]
15. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974.
Liu J; Pan S; Hsieh MH; Ng N; Sun F; Wang T; Kasibhatla S; Schuller AG; Li AG; Cheng D; Li J; Tompkins C; Pferdekamper A; Steffy A; Cheng J; Kowal C; Phung V; Guo G; Wang Y; Graham MP; Flynn S; Brenner JC; Li C; Villarroel MC; Schultz PG; Wu X; McNamara P; Sellers WR; Petruzzelli L; Boral AL; Seidel HM; McLaughlin ME; Che J; Carey TE; Vanasse G; Harris JL
Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20224-9. PubMed ID: 24277854
[TBL] [Abstract][Full Text] [Related]
16. Discovery and Optimization of a Porcupine Inhibitor.
Duraiswamy AJ; Lee MA; Madan B; Ang SH; Tan ES; Cheong WW; Ke Z; Pendharkar V; Ding LJ; Chew YS; Manoharan V; Sangthongpitag K; Alam J; Poulsen A; Ho SY; Virshup DM; Keller TH
J Med Chem; 2015 Aug; 58(15):5889-99. PubMed ID: 26110200
[TBL] [Abstract][Full Text] [Related]
17. Notum deacylates Wnt proteins to suppress signalling activity.
Kakugawa S; Langton PF; Zebisch M; Howell S; Chang TH; Liu Y; Feizi T; Bineva G; O'Reilly N; Snijders AP; Jones EY; Vincent JP
Nature; 2015 Mar; 519(7542):187-192. PubMed ID: 25731175
[TBL] [Abstract][Full Text] [Related]
18. Identification of key residues and regions important for porcupine-mediated Wnt acylation.
Rios-Esteves J; Haugen B; Resh MD
J Biol Chem; 2014 Jun; 289(24):17009-19. PubMed ID: 24798332
[TBL] [Abstract][Full Text] [Related]
19. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma.
Jiang X; Hao HX; Growney JD; Woolfenden S; Bottiglio C; Ng N; Lu B; Hsieh MH; Bagdasarian L; Meyer R; Smith TR; Avello M; Charlat O; Xie Y; Porter JA; Pan S; Liu J; McLaughlin ME; Cong F
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12649-54. PubMed ID: 23847203
[TBL] [Abstract][Full Text] [Related]
20. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
